Search by CAS No , Chemical Name or Molecular Formula
"Crofelemer (USAN, trade name Mytesi) is a botanical drug for the treatment of diarrhoea associated with anti-HIV drugs such as nucleoside analog reverse transcriptase inhibitors and protease inhibitors. Other possible uses include diarrhoea in children, acute infectious diarrhoea, and diarrhoea in patients with irritable bowel syndrome. It is a purified oligomeric proanthocyanidin from \"dragon's blood\", the sap of the South American tree Croton lechleri.
Crofelemer treats the symptoms of disease, but it is not used to treat infectious diarrhoea (diarrhoea caused by infection of the digestive system by a bacterium, virus or parasite).
It was initially developed by Napo Pharmaceuticals, which licensed it to Glenmark Pharmaceuticals in 140 emerging markets and to Salix Pharmaceuticals in the US, EU and some other markets. A Phase III clinical trial for diarrhoea in HIV patients was completed in 2012, and the drug was approved by the US Food and Drug Administration (FDA) on 31 December 2012.",""
Crofelemer is a drug under development for the treatment of diarrhea associated with anti-HIV drugs such as nucleoside analog reverse transcriptase inhibitors and protease inhibitors. Other possible uses include diarrhea in children, acute infectious diarrhea.
Verkman, A. S. (2009); H. Spreitzer (10 September 2012)
We normally respond within 8 hours.
This page contains information about Crofelemer Cas # 148465-45-6 and its API Standards.
Crofelemer Crofelemer Worldwide Suppliers of Crofelemer https://www.clearsynth.com/en/CSO11215.html API Standards Clearsynth 148465-45-6
Product rating: 9 Crofelemer based on 20 ratings
Keywords: API Standards CS-O-11215 Crofelemer Crofelemer 148465-45-6 857.83 C15O6,7H12)n
Internal standard, Internal standard Crofelemer, HPLC-MS method validation, HPLC-MS method validation Crofelemer, LC-MS-MS method validation, LC-MS-MS method validation Crofelemer, Deuterated internal standard, Deuterated internal standard Crofelemer, Deuterated Crofelemer, Deuterium labeled Crofelemer, Quantitative bioanalytical methods, Quantitative bioanalytical methods Crofelemer, Blood samples Crofelemer, Blood concentrations, Heavy drugs, Analysis, Analysis Crofelemer, Clinical diagnostic, Clinical diagnostic Crofelemer, Dosing Crofelemer, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945